União Europeia - maltês - EMA (European Medicines Agency)

n.v. organon - follitropin beta - infertility; hypogonadism - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - fil-mara:puregon huwa indikat għall-kura ta 'nisa infertilità fis-sitwazzjonijiet kliniċi li ġejjin:meta ma jkunx hemm ovulazzjoni (inkluż l-sindromu tal-ovarji poliċistiċi, pcos) fin-nisa li ġew jirrispondux għall-kura bi clomifene citrate;iperstimulazzjoni kkontrollata ta' l-ovarji sabiex tistimula l-iżvilupp tal-follikuli multipli fi programmi ta ' riproduzzjoni medikament assistiti (e. fil-fertilizzazzjoni in vitro / - trasferiment tal-embriju (ivf/et), il-gameti intrafallopian trasferiment (gift) u intracytoplasmic-injezzjoni ta ' l-isperma (icsi)). fir-raġel:defiċjenza ta ' spermatoġenesi minħabba ipogonadiżmu ipogonadotrofiku.

União Europeia - maltês - EMA (European Medicines Agency)

pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - immunostimulanti, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 u 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. fir-rigward tal-deċiżjoni li tinbeda l-kura f'pazjenti pedjatriċi ara sezzjonijiet 4. 2, 4. 4 u 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 u 5. għall-vajrus tal-epatite Ċ (hcv) ġenotip attività speċifika, ara sezzjonijiet 4. 2 u 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. meta jiddeċiedu li tibda l-kura fit-tfulija, huwa importanti li tikkunsidra l-inibizzjoni tat-tkabbir indotta mill-terapija kombinata. l-riversibbiltà ta ' inibizzjoni tat-tkabbir huwa inċert. id-deċiżjoni li l-kura għandha tittieħed fuq bażi ta'każ b'każ (ara sezzjoni 4.

União Europeia - maltês - EMA (European Medicines Agency)

theramex ireland limited - follitropin alfa - anovulazzjoni - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - fl-adulti womenanovulation (inklużi l-sindromu tal-ovarji poliċistiċi) fin-nisa li ġew jirrispondux għall-kura bi clomifene citrate;l-istimulazzjoni tal-multifollicular-iżvilupp fil-nisa li għaddejjin minn ovulazzjoni mgħaġġla hija għall-teknoloġiji ta 'riproduzzjoni assistita (art) bħall-fertilizzazzjoni in vitro (ivf), gameti intra-fallopjan-trasferiment u l-zygote intra-fallopjan trasferiment;ovaleap fil-assoċjazzjoni ma luteinising hormone (lh) preparazzjoni huwa rakkomandat għall-istimulazzjoni ta' l-iżvilupp follikulari fin-nisa bil-qawwi ta ' lh u fsh. fi provi kliniċi dawn il-pazjenti ġew definiti bil-livelli endoġeni tas-serum lh < 1. 2 iu/l. fl-adulti menovaleap huwa indikat għall-istimulazzjoni ta 'spermatoġenesi f'irġiel li għandhom nuqqas konġenitali jew akkwistati hypogonadotropic ipogonadotrofiku ma' gonadotropin korjonika umana (hcg) it-terapija.

União Europeia - maltês - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - polycythemia vera - immunostimulanti, - besremi huwa indikat bħala monoterapija fl-adulti għat-trattament ta ' poliċitemija vera mingħajr sintomatika splenomegalija.

União Europeia - maltês - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - anti-epilettiċi, - epidyolex huwa indikat għall-użu bħala terapija aġġuntiva ta 'aċċessjonijiet assoċjati mas-sindrome lennox gastaut (lgs) jew sindromu ta'dravet (ds), flimkien ma' clobazam, għall-pazjenti 2 snin ta ' età u anzjani.

União Europeia - maltês - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - obeżità - preparazzjonijiet ta 'kontra l-ossessjoni, esklużi prodotti tad-dieta - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

União Europeia - maltês - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - imidakloprid, moksidektin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). il-prodott mediċinali veterinarju jista 'jintuża bħala parti minn strateġija ta' trattament għal dermatite tal-allerġija tal-briegħed (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). il-prodott mediċinali veterinarju jista 'jintuża bħala parti minn strateġija ta' trattament għal dermatite tal-allerġija tal-briegħed (fad).

União Europeia - maltês - EMA (European Medicines Agency)

intervet international bv - azagly-nafarelin - ormoni u analogi pitwitarji u ipotalamiċi - dogs; salmonidae (salmonid fish) - female salmonid fish bħas-salamun tal-atlantiku (salmo salar), trota tal-qawsalla (oncorhynchus mykiss), trota kannella (salmo trutta) u l-charr arktiku (salvelinus alpinus)induzzjoni u sinkronizzazzjoni ta 'l-ovulazzjoni għall-produzzjoni ta' bajd bil-għajn u ħut żgħir. klieb (klieb)l-prevenzjoni tal-funzjoni gonadali fil-klieb nisa permezz imblokk fit-tul tas-sintesi tal-gonadotrofina.

União Europeia - maltês - EMA (European Medicines Agency)

le vet beheer b.v.  - meloxicam - oxicams - Żwiemel - tnaqqis ta 'infjammazzjoni u eżenzjoni ta' uġigħ kemm f'mard muskolu-skeletriku akut kif ukoll kroniku fiż-żwiemel.

União Europeia - maltês - EMA (European Medicines Agency)

intervet international bv - fenbendazole - anthelmintics, , il-benżimidażoli u sustanzi relatati, fenbendażol - pigs; chicken - għat-trattament u l-kontroll tal-ħniex gastro-intestinali fil-ħnieżer infettati bil -: ascaris suum (adulti, intestinali u l-migrazzjoni-istadji tal-larva);oesophagostomum spp. (adulti istadji);trichuris suis (adulti istadji). għat-trattament tal-ħniex gastro-intestinali fit-tiġieġ infettati bil -: ascaridia galli (l5 u l-adulti l-istadji);heterakis gallinarum (l5 u l-adulti l-istadji);capillaria spp. (l5 u l-adulti l-istadji).